IP Library Granted Patent US 7,692,028
Granted Patent B2
US 7,692,028 · App. 12/000,512 · Granted Apr 6, 2010

2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Assignee: UCB Pharma, S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,692,028
App. No.
12/000,512
Granted
Apr 6, 2010
Kind
B2
Abstract

The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.

Claims (31)

1. A compound of formula (AA-XIX)

wherein

X is —CA 1 NR 5 R 6 , —CA 1 OR 7 , —CA 1 -R 8 or —CN;

A 1 is oxygen, sulfur or —NR 9 ;

R 1 is hydrogen, alkyl, aryl or —CH 2 —R 1a wherein R 1a is aryl, halogen, hydroxy, amino, nitro or cyano;

R 2 and R 4 are hydrogen;

R 3 is halogen, thiol, nitro, nitrooxy, cyano, azido, carboxy, amido, sulfonic acid, sulfonamide, alkyl, alkenyl, alkynyl, ester, ether, aryl, tetrazolyl, thiazolyl, thienyl, furyl, pyrrolyl, pyridinyl, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, alkylthio, alkenylthio, alkynylthio, arylthio, formyl, acetyl, propionyl, isobutyryl, valeryl, lauroyl, heptanedioyl, cyclohexanecarbonyl, crotonoyl, furmaroyl, acyloyl, benzoyl, naphtoyl, 4-carboxybutanoyl, oxalyl, ethoxalyl, cysteinyl, oxamoyl, alkylsulfonyl, alkenylsulfonyl, alkynylsulfonyl, arylsulfonyl, alkylsulfinyl, alkenylsulfinyl, alkynylsulfinyl or arylsulfinyl;

R 5 , R 6 , R 7 and R 9 are the same or different and each is independently hydrogen, hydroxy, alkyl, aryl, alkoxy, alkenyloxy, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy or arylakoxy; and

R 8 is hydrogen, hydroxy, thiol, halogen, alkyl, aryl, alkylthio, alkenylthio, or alkynylthio.

2. A compound of formula (AA-XIX) according to claim 1 wherein

X is —CA 1 NR 5 R 6 ;

A 1 is oxygen;

R 1 is alkyl;

R 2 and R 4 are hydrogen;

R 3 is alkyl; and

R 5 and R 6 are hydrogen.

3. A compound of formula (AA-XIX) according to claim 1 wherein when the carbon atom to which R 1 is attached is asymmetric, said carbon atom is in the “S”-configuration.

4. A method of preparation of compound of formula (I)

wherein

X is —CA 1 NR 5 R 6 , —CA 1 OR 7 , —CA 1 -R 8 or —CN;

A 1 is oxygen, sulfur or —NR 9 ;

R 1 is hydrogen, alkyl, aryl or —CH 2 —R 1a wherein R 1a is aryl, halogen, hydroxy, amino, nitro or cyano;

R 3 is halogen, thiol, nitro, nitrooxy, cyano, azido, carboxy, amido, sulfonic acid, sulfonamide, alkyl, alkenyl, alkynyl, ester, ether, aryl, tetrazolyl, thiazolyl, thienyl, furyl, pyrrolyl, pyridinyl, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, alkylthio, alkenylthio, alkynylthio, arylthio, formyl, acetyl, propionyl, isobutyryl, valeryl, lauroyl, heptanedioyl, cyclohexanecarbonyl, crotonoyl, furmaroyl, acyloyl, benzoyl, naphtoyl, 4-carboxybutanoyl, oxalyl, ethoxalyl, cysteinyl, oxamoyl, alkylsulfonyl, alkenylsulfonyl, alkynylsulfonyl, arylsulfonyl, alkylsulfinyl, alkenylsulfinyl, alkynylsulfinyl or arylsulfinyl;

R 3a is hydrogen;

R 5 , R 6 , R 7 and R 9 are the same or different and each is independently hydrogen, hydroxy, alkyl, aryl, alkoxy, alkenyloxy, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy or arylakoxy; and

R 8 is hydrogen, hydroxy, thiol, halogen, alkyl, aryl, alkylthio, or alkenylthio, alkynylthio;

with the proviso that when the compound is a mixture of all possible isomers, X is —CONR 5 R 6 and R 1 is hydrogen, methyl, ethyl or propyl then R 3 and R 3a substitution is other than mono-, di-methyl or mono-ethyl;

and that when R 1 and R 3a are both hydrogen and X is —CONR 5 R 6 then R 3 is different from carboxy, ester, amido, substituted oxo-pyrrolidine, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, methyl, naphtyl, phenyl optionally substituted by oxy derivatives or in the para position by an halogen atom;

which comprises reduction of a compound of formula (AA-XIX)

4 according to claim 1 .

5. The method of preparation of compound of formula (I) according to claim 4 wherein the reduction is performed in the presence of Pd/C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2015
From: UCB PHARMA, S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 035112/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2008
From: UCB, S.A.
To: UCB PHARMA, S.A.
Reel/Frame 021773/0126 →
Priority Claims (1)
GB 0004297.8 · Feb 23, 2000 · national
Continuity (4)
Continuation 1104317600 · Jan 27, 2005
Division 1069391700 · Oct 28, 2003
Division 1020426600
Related Publication 20080097109A1 · Apr 24, 2008